CAAS Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,570
Closed -$1.46M 674
2023
Q2
$1.42M Buy
20,570
+17,070
+488% +$1.21M 0.1% 206
2023
Q1
$260K Buy
+3,500
New +$293K 0.01% 505
2022
Q3
Sell
-3,600
Closed -$334K 863
2022
Q2
$334K Sell
3,600
-7,100
-66% -$693K 0.02% 602
2022
Q1
$1.08M Buy
+10,700
New +$1.12M 0.04% 294
2021
Q4
Sell
-13,900
Closed -$1.28M 896
2021
Q3
$1.18M Buy
13,900
+1,900
+16% +$159K 0.02% 455
2021
Q2
$1M Buy
+12,000
New +$983K 0.02% 551

Other funds holding CVS

CAAS Capital Management's CVS Position: Q3 2023 in Review

CAAS Capital Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 20,570 shares — an estimated $1.46M sold.

CAAS Capital Management first reported a position in CVS in Q2 2021 and held it in 6 quarters. The position peaked at $1.42M in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • CAAS Capital Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • CAAS Capital Management sold 20,570 CVS Health shares in Q3 2023, an estimated $1.46M.
  • CAAS Capital Management first reported a position in CVS Health in Q2 2021 and held it in 6 quarters.
  • CAAS Capital Management's CVS Health position peaked at $1.42M in Q2 2023.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on CAAS Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.